Related Experiment Video

Updated: Jun 27, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
12:18

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)

Published on: February 9, 2011

Treatment and recurrence management of staphylococcal infections: community-acquired MRSA

Pramodini Kale-Pradhan1, Leonard B Johnson

  • 1Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, St John Hospital and Medical Center, 22101 Moross Road, Detroit, MI 48236, USA. pkale@wayne.edu

Expert Review of Anti-Infective Therapy
|December 5, 2008
PubMed

Insights

Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) infections require diverse treatments due to toxin genes. This review explores therapeutic options and relapse prevention strategies for MRSA skin infections.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Dermatology

Background:

  • Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) is increasingly prevalent, altering skin and soft-tissue infection treatment.
  • CA-MRSA strains often possess Panton-Valentine leukocidin toxin genes and show susceptibility to non-beta-lactam antibiotics.
  • Current treatment paradigms are shifting due to the evolving nature of MRSA.

Purpose of the Study:

  • To review current therapeutic options for presumed and definite CA-MRSA infections.
  • To discuss strategies for preventing frequent relapses associated with CA-MRSA.
  • To clarify the optimal approach for eliminating CA-MRSA colonization.

Main Methods:

  • Literature review of therapeutic strategies for CA-MRSA.
  • Analysis of antibiotic susceptibility patterns for CA-MRSA strains.
  • Examination of clinical outcomes and relapse rates in CA-MRSA infections.

Main Results:

  • A broad spectrum of therapies is available for CA-MRSA infections.
  • CA-MRSA strains exhibit specific genetic profiles, including toxin gene carriage.
  • Relapse is a common issue in CA-MRSA infections, with unclear optimal eradication methods.

Conclusions:

  • Effective management of CA-MRSA infections involves a range of antimicrobial agents.
  • Further research is needed to establish definitive strategies for MRSA decolonization and relapse prevention.
  • Understanding CA-MRSA epidemiology and virulence factors is crucial for guiding treatment decisions.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...